Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine.
Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine.



To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine.



Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment.



In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p < .001) or drug charges (25.0% vs. 17.5%, p = .015), as well as the mean number of cases (0.97 vs. 0.63, p = .002) and drug cases (0.38 vs. 0.23, p = .008), while those who initiated buprenorphine did not have significant changes in any of these measures. On multivariable analysis, the strongest predictor of criminal charges in the 2 years after treatment enrollment was prior charges (adjusted odds ratio 3.35, 95% confidence interval, 2.24-5.01).



Enrollment in office-based buprenorphine treatment did not appear to have the same beneficial effect on subsequent criminal charges as methadone maintenance. If this observation is replicated in other settings, it may have implications for matching individuals to these treatment options.
a Department of Medicine , Johns Hopkins University , Baltimore , Maryland , USA.
Darius A
DA
Rastegar
b Healthcare for the Homeless , Baltimore , Maryland , USA.
Sarah
S
Sharfstein Kawasaki
c Department of Psychiatry and Behavioral Science and Addiction Treatment Services , Johns Hopkins University , Baltimore , Maryland , USA.
Van L
VL
King
d Albert Einstein College of Medicine/Montefiore Medical Center , Bronx , New York , USA.
Elizabeth E
EE
Harris
c Department of Psychiatry and Behavioral Science and Addiction Treatment Services , Johns Hopkins University , Baltimore , Maryland , USA.
Robert K
RK
Brooner
D002047:Buprenorphine; D057237:Criminals; D006801:Humans; D008691:Methadone; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders
D002047:Buprenorphine; D008691:Methadone
Crime; buprenorphine; methadone; opioid agonist treatment; opioid-related disorders